Neuropace INC Form 4 insider transactions

OrbiMed Advisors LLC, a significant shareholder of NeuroPace Inc, has sold a portion of its common stock holdings in a series of transactions between April 16 and April 18, 2024.

OrbiMed Advisors LLC, a significant shareholder of NeuroPace Inc, has sold a portion of its common stock holdings in two transactions on April 11 and 12, 2024.

Chief Medical Officer Martha Morrell reports acquiring 12,500 shares of common stock and 24,950 stock options in NeuroPace Inc.

NeuroPace's Chief Financial Officer, Rebecca Kuhn, reported the acquisition of 12,500 shares of common stock and 24,950 stock options.

NeuroPace's CEO, Joel Becker, reports the acquisition of stock options and restricted stock units (RSUs) in the company.